Verastem Shs (VSTM) Reports In-Line Q2 Loss of 34c/Share

Verastem Shs (NASDAQ: VSTM) reported Q2 EPS of ($0.34), in-line with the analyst estimate of ($0.34).

The Estimize consensus was $0.00 and $0 , respectively.

For earnings history and earnings-related data on Verastem Shs (VSTM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
• Turning Point Brands (TPB) PT Lowered to $90 at Oppenheimer